Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine-District of Columbia, August 2022.
Ogale YP, Baird N, Townsend MB, Berry I, Griffin I, Lee M, Ashley P, Rhodes T, Notigan T, Wynn N, Kling C, Smith T, Priyamvada L, Carson WC, Navarra T, Dawson P, Weidle PJ, Willut C, Mangla AT, Satheshkumar PS, Hutson CL, Jackson DA, Waltenburg MA; DC Mpox Response Project Team.
Ogale YP, et al.
Clin Infect Dis. 2023 Jul 26;77(2):298-302. doi: 10.1093/cid/ciad145.
Clin Infect Dis. 2023.
PMID: 36916132